Single-Cell Characterization of the Immune and Leukemic Cells Following Anti-TIM3 and Hypomethylating Agent Combination Therapy in Patients with AML or MDS

Jani Huuhtanen,Oscar Bruck,Karita Peltonen,Anna Kreutzman,Olli Dufva,Matti Kankainen,Mette Ilander,Hanna Lahteenmaki,Tiina Kasanen,Jay Klievink,Mika Kontro,Elena J. Orlando,Viviana Cremasco,Joel Wagner,Marc Pelletier,Harri Lahdesmaki,Catherine A. Sabatos-Peyton,Mikael L. Rinne,Kimmo Porkka,Satu Mustjoki

BLOOD（2021）

Cited 0|Views21
No score
Abstract
Background
More
Translated text
Key words
hypomethylating agent combination therapy,leukemic cells,immune,aml,single-cell,anti-tim
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined